Bisphosphonates induce apoptosis in mouse macrophage‐like cells in vitro by a nitric oxide‐independent mechanism

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Bone and Mineral Research

• Publication date

  1996-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jbmr.5650111015PMID 8889848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate

  2004cited by this paper
• Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

  1995cited by this paper
• The role of DNA fragmentation in apoptosis.

  1995cited by this paper
• Nitric oxide: A cytokine‐induced regulator of bone resorption

  1995cited by this paper
• Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds.

  1995cited by this paper
• Cytokine-induced nitric oxide production inhibits bone resorption in mouse bone marrow cultures by inducing apoptosis in osteoclast progenitors

  1995cited by this paper
• Cellular uptake of bisphosphonates: Localisation using fluorescently- labelled alendronate

  1995cited by this paper
• Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes.

  1995cited by this paper
• Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.

  1995cited by this paper
• Bone cell function, regulation, and communication: A role for nitric oxide

  1995cited by this paper
• Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.

  1994cited by this paper
• Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum.

  1994cited by this paper
• Redox signaling: nitrosylation and related target interactions of nitric oxide.

  1994cited by this paper
• Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.

  1994cited by this paper
• Inhibition of topoisomerase II by aurintricarboxylic acid: implications for mechanisms of apoptosis.

  1994cited by this paper
• Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase.

  1994cited by this paper
• Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold dictyostelium discoideum

  1994cited by this paper
• Cell nucleus and DNA fragmentation are not required for apoptosis

  1994cited by this paper
• Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

  1993cited by this paper
• Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.

  1993cited by this paper
• Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates.

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme

  1993cited by this paper
• Nitric oxide-mediated apoptosis in murine peritoneal macrophages.

  1993cited by this paper
• Nitric oxide synthase induces macrophage death by apoptosis.

  1993cited by this paper
• Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.

  1992cited by this paper
• DNA damage and mutation in human cells exposed to nitric oxide in vitro.

  1992cited by this paper
• Features of apoptotic cells measured by flow cytometry.

  1992cited by this paper
• Bisphosphonates

  1991cited by this paper
• Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

  1991cited by this paper
• Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts, and bone

  1991cited by this paper
• Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

  1991cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Interleukin 1 is processed and released during apoptosis.

  1991cited by this paper
• Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate

  1990cited by this paper
• Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

  1990cited by this paper
• Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy

  1990cited by this paper
• Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

  1990cited by this paper
• Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

  1990cited by this paper
• Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage

  1990cited by this paper
• DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels.

  1990cited by this paper
• Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.

  1990cited by this paper
• NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.

  1989cited by this paper
• Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.

  1989cited by this paper
• Calcium‐activated DNA fragmentation kills immature thymocytes

  1989cited by this paper
• The liposome-mediated macrophage ‘suicide’ technique

  1989cited by this paper
• Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

  1989cited by this paper
• The liposome-mediated macrophage 'suicide' technique.

  1989cited by this paper
• Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.

  1989cited by this paper
• Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonate

  1988cited by this paper
• The acute-phase response after bisphosphonate administration

  1987cited by this paper
• Effect of bisphosphonates on proliferation and viability of mouse bone marrow‐derived macrophages

  1987cited by this paper
• Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages

  1986cited by this paper
• Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

  1986cited by this paper
• Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate.

  1986cited by this paper
• Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

  1986cited by this paper
• Inhibition of bone resorption by difluoromethylene diphosphonate in organ culture.

  1983cited by this paper
• Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

  1982cited by this paper
• Increase in fatty acid oxidation in calvaria cells cultured with diphosphonates.

  1981cited by this paper
• APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

  1980cited by this paper
• The effects of calcitonin and colchicine on the cellular response to diphosphonate.

  1980cited by this paper
• Diphosphonates inhibit bone resorption by macrophages in vitro

  1980cited by this paper
• Cell death: the significance of apoptosis.

  1980cited by this paper
• Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis.

  1979cited by this paper
• The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture.

  1978cited by this paper
• The alteration of osteoclast morphology by diphosphonates in bone organ culture

  1976cited by this paper
• The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant induced arthritis in rats

  1971cited by this paper
• Mammalian chain initiation: The effect of aurintricarboxylic acid

  1971cited by this paper

• Comparing the stability of implants coated with nano PLGA-alendronate sodium: an in-vivo study

  2025cites this paper
• The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential

  2024cites this paper
• Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy

  2024cites this paper
• Exploration of mechanical properties and osseointegration capacity of porous PEEK composites containing strontium and alendronate under 3D printing: an emerging bone implant

  2024cites this paper
• Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases

  2022cites this paper
• Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential.

  2022cites this paper
• Bisphosphonate type-dependent cell viability suppressive effects of carbon nanohorn-calcium phosphate-bisphosphonate nanocomposites.

  2022cites this paper
• Bioactive Coatings With Anti-osteoclast Therapeutic Agents for Bone Implants: Enhanced Compliance and Prolonged Implant Life.

  2022cites this paper
• Ibandronate-Loaded Carbon Nanohorns Fabricated Using Calcium Phosphates as Mediators and Their Effects on Macrophages and Osteoclasts.

  2021cites this paper
• Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study

  2021cites this paper
• Molecular mechanisms of actions of bisphosphonates and new insights into their effects outside the skeleton.

  2020cites this paper
• ZOLEDRONATE-ASSOCIATED RECURRENCE OF OSTEONECROSIS OF JAWS

  2020cites this paper
• Assessment of bisphosphonate treated-osteoblast behaviors by conventional assays and a simple digital image analysis.

  2020cites this paper
• Medication-Related Osteonecrosis of the Jaws.

  2019cites this paper
• Examination of the periosteal microcirculation of long bones. Consequences of estrogen deficiency

  2019cites this paper
• Local, intra-articular delivery of zoledronic acid as a disease-modifying therapeutic for post-traumatic osteoarthritis

  2019cites this paper
• Biological effects of aromatic bis[aminomethylidenebis(phosphonic)] acids in osteoclast precursors in vitro

  2019cites this paper
• Clinical Pharmacology of Bisphosphonates

  2019cites this paper
• Inhibition of macrophage viability by bound and free bisphosphonates.

  2019cites this paper
• Microcirculatory consequences of limb ischemia/reperfusion in ovariectomized rats treated with zoledronic acid

  2019cites this paper
• Drug-Induced Musculoskeletal Syndromes and Soft-Tissue Rheumatism

  2019cites this paper
• Clodronate: A Vesicular ATP Release Blocker.

  2018cites this paper
• Management of multiple myeloma bone disease: impact of treatment on renal function

  2018cites this paper
• Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer

  2018cites this paper
• Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes

  2018cites this paper
• Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells

  2017cites this paper
• Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review

  2017cites this paper
• Scanning electron microscopy study of new bone formation following small and large defects preserved with xenografts supplemented with pamidronate-A pilot study in Fox-Hound dogs at 4 and 8 weeks.

  2017cites this paper
• Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial.

  2017cites this paper
• A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions

  2017cites this paper
• Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain

  2017cites this paper
• Bisphosphonates pour le traitement du syndrome douloureux régional complexe de type 1 : revue systématique de la littérature et méta-analyse des essais randomisés versus placebo

  2017cites this paper
• Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo.

  2017cites this paper
• Impairment of cold injury-induced muscle regeneration in mice receiving a combination of bone fracture and alendronate treatment

  2017cites this paper
• Apoptotic pathways of macrophages within osteolytic interface membrane in periprosthestic osteolysis after total hip replacement

  2017cites this paper
• Tumor-associated macrophages and anti-tumor therapies: complex links

  2016cites this paper
• Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid.

  2016cites this paper
• Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer.

  2016cites this paper
• Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw

  2016cites this paper
• The tumour microenvironment as a potential therapeutic target in breast cancer

  2016influential citation
• Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ).

  2016cites this paper
• Safety of I.V. Nonnitrogen bisphosphonates on the occurrence of osteonecrosis of the jaw: long-term follow-up on prostate cancer patients.

  2015cites this paper
• Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases

  2015cites this paper
• Cellular and molecular actions of bisphosphonates

  2015cites this paper
• Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ)

  2015cites this paper
• Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells

  2014cites this paper
• Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin–Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma

  2014influential citation
• Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.

  2014cites this paper
• Small Molecule Therapeutics Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin – Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma

  2014influential citation
• Differential impact of the Bisphosphonate Alendronate on undifferentiated and terminally differentiated human myogenic cells

  2014cites this paper
• Bisphosphonates in Complex Regional Pain syndrome type I: how do they work?

  2014cites this paper
• Effects of antiresorptive agents on inflammation and bone regeneration in different osseous sites - experimental and clinical studies

  2014cites this paper
• In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes

  2014cites this paper
• Macrophages as potential targets for zoledronic acid outside the skeleton—evidence from in vitro and in vivo models

  2013cites this paper
• Osteonecrosis of the Jaw and Atypical Femoral Fractures

  2013cites this paper
• Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells

  2013cites this paper
• Anti-Osteoporotic Drugs and Vascular Calcification: The Bidirectional Calcium Traffic

  2013cites this paper
• YM‐175 induces apoptosis of human native monocyte‐lineage cells via inhibition of prenylation

  2012cites this paper
• Mevalonate-suppressive dietary isoprenoids for bone health.

  2012cites this paper
• REVIEWS: CURRENT TOPICS Mevalonate-suppressive dietary isoprenoids for bone health

  2012cites this paper
• Kupffer cells support extramedullary erythropoiesis induced by nitrogen-containing bisphosphonate in splenectomized mice.

  2011cites this paper
• THE CYTOTOXIC AND APOPTOTIC-NECROTIC EFFECTS OF WHITENING MATERIALS ON HUMAN GINGIVAL FIBROBLASTS

  2011cites this paper
• Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts

  2011cites this paper
• Pathways of macrophage apoptosis within the interface membrane in aseptic loosening of prostheses.

  2011cites this paper
• Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw

  2011cites this paper
• Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.

  2011cites this paper
• Biochemical and molecular mechanisms of action of bisphosphonates.

  2011cites this paper
• Osteonecrosis of the jaw and the role of macrophages.

  2011cites this paper
• Tumour macrophages as potential targets of bisphosphonates

  2011cites this paper
• Alendronate reduces osteoclast precursors in osteoporosis

  2010cites this paper
• Bisphosphonates, Bone Health and the Clinical Biology of Bone Metastases from Breast Cancer

  2010cites this paper
• Assessment of bisphosphonate activity in vitro.

  2010cites this paper
• Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death.

  2010cites this paper
• Differential Poly(I:C) Responses of Human Vγ9Vδ2 T Cells Stimulated with Pyrophosphates Versus Aminobisphosphonates

  2009cites this paper
• Whither goest the lifeless osteoclast

  2009cites this paper
• The deceiving appearances of osteoclasts.

  2009cites this paper
• Prolonged Antiresorptive Treatment of Lytic Prostate Cancer Xenografts in Mouse Bone Results in Tumor Necrosis

  2009cites this paper
• IDENTIFICAZIONE DI BERSAGLI TERAPEUTICI E REALIZZAZIONE DI TECNOLOGIE INNOVATIVE IN ONCOLOGIA ORTOPEDICA

  2009cites this paper
• Genetics of the bone response to bisphosphonate treatments.

  2009cites this paper
• Nitric oxide: novel therapy for osteoporosis

  2008cites this paper
• Nitric oxide: novel therapy for osteoporosis.

  2008cites this paper
• Skeletal Effects of Nitric Oxide

  2008cites this paper
• Nitricoxide:noveltherapy forosteoporosis

  2008cites this paper
• R115777 (Zarnestra®)/Zoledronic acid (Zometa®) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl‐2 and bad phosphorylation

  2007cites this paper
• The Molecular Mechanisms of Action of Bisphosphonates

  2007cites this paper
• Administration of pamidronate alters bone-titanium attachment in the presence of endotoxin-coated polyethylene particles.

  2007cites this paper
• Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis

  2007cites this paper
• Vitamin K2 improves bone strength in postmenopausal women

  2007cites this paper
• Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

  2007cites this paper
• Bisphosphonate-related jaw necrosis--severe complication in maxillofacial surgery.

  2007cites this paper
• Rationale for Using Nitric Oxide Donor Therapy for Prevention of Bone Loss and Treatment of Osteoporosis in Humans

  2007cites this paper
• Significance and impact of bisphosphonate-induced acute phase responses

  2007cites this paper
• Risedronate Reduces Osteoclast Precursors and Cytokine Production in Postmenopausal Osteoporotic Women

  2007cites this paper
• Editorial · Editorial comments

  2007cites this paper
• Inorganic Polyphosphate: a Possible Stimulant of Bone Formation

  2007cites this paper
• Anti-tumour effects of bisphosphonates in breast cancer

  2006cites this paper
• Effects of nitric oxide synthase inhibitor ω-Nitro-L-Arginine Methyl Ester, on silica-induced inflammatory reaction and apoptosis

  2006cites this paper
• Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation

  2006cites this paper
• Inhibition of Protein Prenylation by Bisphosphonates Causes Sustained Activation of Rac, Cdc42, and Rho GTPases

  2006cites this paper
• Emerging anti-cancer molecular mechanisms of aminobisphosphonates.

  2006cites this paper